Peters S - Search Results

1

[Oncology, what's new in 2018].

Latifyan S, Kakourou A, Ozdemir B, Zaman K, Vernadou A, Berthold D, Abdelhamid K, Bouchaab H, Peters S, Montemurro M, Aedo V, Michielin O, Zimmermann S, Stravodimou A. Latifyan S, et al. Among authors: peters s. Rev Med Suisse. 2019 Jan 9;15(N° 632-633):78-81. Rev Med Suisse. 2019. PMID: 30629376 French.

2

Pulmonary sarcoid-like granulomatosis induced by ipilimumab.

Berthod G, Lazor R, Letovanec I, Romano E, Noirez L, Mazza Stalder J, Speiser DE, Peters S, Michielin O. Berthod G, et al. Among authors: peters s. J Clin Oncol. 2012 Jun 10;30(17):e156-9. doi: 10.1200/JCO.2011.39.3298. Epub 2012 Apr 30. J Clin Oncol. 2012. PMID: 22547608 No abstract available.

3

Dramatic response induced by vemurafenib in a BRAF V600E-mutated lung adenocarcinoma.

Peters S, Michielin O, Zimmermann S. Peters S, et al. J Clin Oncol. 2013 Jul 10;31(20):e341-4. doi: 10.1200/JCO.2012.47.6143. Epub 2013 Jun 3. J Clin Oncol. 2013. PMID: 23733758 No abstract available.

4

Cerebral nocardiosis mimicking multiple brain metastases in a patient with locally advanced non-small-cell lung cancer.

Voide C, Zimmermann S, Adjei AA, Betticher DC, Meuli R, Prod'hom G, Giulieri S, Peters S. Voide C, et al. Among authors: peters s. J Thorac Oncol. 2014 Mar;9(3):e24-6. doi: 10.1097/JTO.0000000000000018. J Thorac Oncol. 2014. PMID: 24518096 Free article. No abstract available.

5

Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases.

Zimmermann S, Dziadziuszko R, Peters S. Zimmermann S, et al. Among authors: peters s. Cancer Treat Rev. 2014 Jul;40(6):716-22. doi: 10.1016/j.ctrv.2014.03.005. Epub 2014 Apr 8. Cancer Treat Rev. 2014. PMID: 24759599 Review.

6

Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: comparative pharmacokinetics and drug-drug interactions.

Peters S, Zimmermann S, Adjei AA. Peters S, et al. Cancer Treat Rev. 2014 Sep;40(8):917-26. doi: 10.1016/j.ctrv.2014.06.010. Epub 2014 Jul 1. Cancer Treat Rev. 2014. PMID: 25027951 Free article.

7

Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient.

Peters S, Bouchaab H, Zimmerman S, Bucher M, Gaide O, Letovanec I, Homicsko K, Michielin O. Peters S, et al. Melanoma Res. 2014 Oct;24(5):496-500. doi: 10.1097/CMR.0000000000000055. Melanoma Res. 2014. PMID: 25185693

8

Investigating barriers in HIV-testing oncology patients. The IBITOP study: phase I.

Merz L, Peters S, Zimmermann S, Cavassini M, Darling K. Merz L, et al. Among authors: peters s. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19622. doi: 10.7448/IAS.17.4.19622. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394126 Free PMC article.

9

Targeted therapy in NSCLC driven by HER2 insertions.

Peters S, Zimmermann S. Peters S, et al. Transl Lung Cancer Res. 2014 Apr;3(2):84-8. doi: 10.3978/j.issn.2218-6751.2014.02.06. Transl Lung Cancer Res. 2014. PMID: 25806285 Free PMC article. Review.

10

Present standards and future perspectives in the treatment of metastatic non-small cell lung cancer.

Zimmermann S, Peters S. Zimmermann S, et al. Among authors: peters s. Cancer Metastasis Rev. 2015 Jun;34(2):173-82. doi: 10.1007/s10555-015-9560-6. Cancer Metastasis Rev. 2015. PMID: 25976078 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,732 results

Search Page

Filters